{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T19:02:16Z","timestamp":1781377336271,"version":"3.54.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","europeanneuropsychopharmacology.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.euroneuro.2014.09.012","type":"journal-article","created":{"date-parts":[[2014,10,16]],"date-time":"2014-10-16T02:00:21Z","timestamp":1413424821000},"page":"1738-1744","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Do antipsychotic drugs increase seizure frequency in epilepsy patients?"],"prefix":"10.1016","volume":"24","author":[{"given":"Mitsutoshi","family":"Okazaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoto","family":"Adachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nozomi","family":"Akanuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichiro","family":"Hara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masumi","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teiichi","family":"Onuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl","key":"10.1016\/j.euroneuro.2014.09.012_bib1","first-page":"S370","article-title":"Treatment of mental disorders in epilepsy patients","volume":"20","author":"Adachi","year":"2005","journal-title":"Jpn. J. Psychiatry Treat."},{"key":"10.1016\/j.euroneuro.2014.09.012_bib2","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1111\/j.1528-1167.2012.03438.x","article-title":"Interictal psychotic episodes in epilepsy: duration and associated clinical factors","volume":"53","author":"Adachi","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.euroneuro.2014.09.012_bib3","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/j.1528-1157.1998.tb01431.x","article-title":"Predictive value of interictal epileptiform discharges during non-REM sleep on scalp EEG recordings for the lateralization of epileptogenesis","volume":"39","author":"Adachi","year":"1998","journal-title":"Epilepsia"},{"issue":"Suppl 1","key":"10.1016\/j.euroneuro.2014.09.012_bib4","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1111\/epi.12102","article-title":"Basic treatment principles for psychotic disorders in patients with epilepsy","volume":"54","author":"Adachi","year":"2013","journal-title":"Epilepsia"},{"issue":"Suppl 2","key":"10.1016\/j.euroneuro.2014.09.012_bib5","first-page":"S68","article-title":"Seizure risk associated with psychotropic drugs: clinical and pharmacokinetic considerations","volume":"53","author":"Alldredge","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.euroneuro.2014.09.012_bib6","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.biopsych.2006.09.023","article-title":"Seizure incidence in psychopharmacological clinical trials: an analysis of Food and Drug Administration (FDA) summary basis of approval reports","volume":"62","author":"Alper","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2014.09.012_bib7","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/WNF.0b013e3181a7fd00","article-title":"Olanzapine-induced clinical seizure: a case report","volume":"32","author":"Behere","year":"2009","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.euroneuro.2014.09.012_bib8","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1528-1157.1989.tb05316.x","article-title":"Proposal for revised classification of epilepsies and epileptic syndromes","volume":"30","year":"1989","journal-title":"Epilepsia"},{"key":"10.1016\/j.euroneuro.2014.09.012_bib9","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s00213-002-1068-4","article-title":"A transcranial magnetic stimulation study of the effects of olanzapine and risperidone on motor cortical excitability in patients with schizophrenia","volume":"162","author":"Fitzgerald","year":"2002","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.euroneuro.2014.09.012_bib10","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1176\/appi.ajp.2009.09060802","article-title":"International consensus study of antipsychotic dosing","volume":"167","author":"Gardner","year":"2012","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2014.09.012_bib11","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1176\/jnp.12.4.458","article-title":"Psychotropic medication use in patients with epilepsy: effect on seizure frequency","volume":"12","author":"Gross","year":"2000","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"issue":"Suppl 25","key":"10.1016\/j.euroneuro.2014.09.012_bib12","first-page":"S1","article-title":"Epilepsy in Iceland","volume":"43","author":"Gudmundsson","year":"1966","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.euroneuro.2014.09.012_bib13","doi-asserted-by":"crossref","first-page":"911","DOI":"10.2165\/00023210-200721110-00004","article-title":"Adverse effects of atypical antipsychotics. Differential risk and clinical implications","volume":"21","author":"Haddad","year":"2007","journal-title":"CNS Drugs"},{"key":"10.1016\/j.euroneuro.2014.09.012_bib14","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.yebeh.2013.02.025","article-title":"Effects of antipsychotic drugs on the duration of interictal psychotic episodes in epilepsy patients","volume":"27","author":"Hara","year":"2013","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.euroneuro.2014.09.012_bib15","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1358\/dot.2003.39.7.799445","article-title":"Antipsychotic medication and seizures: a review","volume":"39","author":"Hedges","year":"2003","journal-title":"Drug Today"},{"key":"10.1016\/j.euroneuro.2014.09.012_bib16","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1001\/jama.1980.03310130038026","article-title":"Epileptogenic side effects of psychotropic drugs","volume":"244","author":"Itil","year":"1980","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.euroneuro.2014.09.012_bib17","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1007\/s00228-010-0861-y","article-title":"Psychiatric comorbidity in patients with epilepsy: a population-based study","volume":"66","author":"Karouni","year":"2010","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.euroneuro.2014.09.012_bib18","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1111\/j.1528-1167.2011.03276.x","article-title":"International consensus clinical practice statements for the treatment of neuropsychiatric conditions associated with epilepsy","volume":"52","author":"Kerr","year":"2011","journal-title":"Epilepsia"},{"issue":"Suppl 2","key":"10.1016\/j.euroneuro.2014.09.012_bib19","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1046\/j.1528-1157.2002.043s2019.x","article-title":"Antipsychotic drugs and epilepsy: indications and treatment guidelines","volume":"43","author":"Koch-Stoecker","year":"2002","journal-title":"Epilepsia"},{"key":"10.1016\/j.euroneuro.2014.09.012_bib20","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.seizure.2009.11.005","article-title":"Seizure risk associated with neuroactive drugs: data from the WHO adverse drug reactions database","volume":"19","author":"Kumlien","year":"2010","journal-title":"Seizure"},{"key":"10.1016\/j.euroneuro.2014.09.012_bib21","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s00213-007-1000-z","article-title":"Moduration of human motor cortex excitability by quetiapine","volume":"196","author":"Lamgguth","year":"2008","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.euroneuro.2014.09.012_bib22","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.seizure.2012.10.009","article-title":"Antipsychotics and seizures: higher risk with atypicals?","volume":"22","author":"Lertxundi","year":"2013","journal-title":"Seizure"},{"key":"10.1016\/j.euroneuro.2014.09.012_bib23","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1212\/WNL.17.9.869","article-title":"Spontaneous epileptic seizures and electroencephalographic changes in the course of phenothiazine therapy","volume":"17","author":"Logothetis","year":"1967","journal-title":"Neurology"},{"key":"10.1016\/j.euroneuro.2014.09.012_bib24","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0163-8343(87)90025-9","article-title":"Seizures with neuroleptics and antidepressants","volume":"9","author":"Markowitz","year":"1987","journal-title":"Gen. Hosp. Psychiatry"},{"key":"10.1016\/j.euroneuro.2014.09.012_bib25","series-title":"The Psychopharmacology","first-page":"107","article-title":"The effect of psychotropic drugs on the seizure threshold: animal studies","author":"Melduram","year":"1988"},{"key":"10.1016\/j.euroneuro.2014.09.012_bib26","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1038\/npp.2011.100","article-title":"D2 receptor block abolishes theta burst stimulation-induced neuroplasticity in the human motor cortex","volume":"36","author":"Monte-Silva","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2014.09.012_bib27","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1523\/JNEUROSCI.5366-08.2009","article-title":"D1-receptor impact on neuroplasticity in humans","volume":"29","author":"Nitsche","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.euroneuro.2014.09.012_bib28","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1212\/WNL.37.9.1525","article-title":"Effect of psychotropic medications on seizure control in patients with epilepsy","volume":"37","author":"Ojemann","year":"1987","journal-title":"Neurology"},{"key":"10.1016\/j.euroneuro.2014.09.012_bib29","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.yebeh.2011.07.016","article-title":"One-year seizure prognosis in epilepsy patients treated with antidepressants","volume":"22","author":"Okazaki","year":"2011","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.euroneuro.2014.09.012_bib30","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1001\/archpsyc.1982.04290020060011","article-title":"Neuroleptic-induced seizures. An in vitro technique for assessing relative risk","volume":"39","author":"Oliver","year":"1982","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2014.09.012_bib31","first-page":"553","article-title":"Therapeutic approach to epileptic patients with psychiatric symptoms","volume":"2","author":"Onuma","year":"1987","journal-title":"Jpn. J. Psychiatry Treat."},{"key":"10.1016\/j.euroneuro.2014.09.012_bib32","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1176\/ajp.117.9.832","article-title":"Thioridazine hydrochloride in the treatment of behavior disorders in epileptics","volume":"117","author":"Pauig","year":"1961","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2014.09.012_bib33","first-page":"78","article-title":"Antipsychotic drugs and seizures","volume":"40","author":"Remick","year":"1979","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2014.09.012_bib34","series-title":"Psychotropic Drug Manual","article-title":"Kou-Seishin-Yaku manual","author":"Toru","year":"2001"},{"key":"10.1016\/j.euroneuro.2014.09.012_bib35","series-title":"Epilepsy. A Comprehensive Textbook","first-page":"2215","article-title":"Psychopharmacology of patients with behavior disorders and epilepsy","author":"Trimble","year":"2008"},{"key":"10.1016\/j.euroneuro.2014.09.012_bib36","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1192\/bjp.178.1.85-a","article-title":"Lowered seizure threshold on olanzapine","volume":"178","author":"Woolley","year":"2001","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2014.09.012_bib37","series-title":"The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines","year":"1992"}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X14002752?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X14002752?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,28]],"date-time":"2018-09-28T13:51:50Z","timestamp":1538142710000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X14002752"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":37,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S0924977X14002752"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2014.09.012","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Do antipsychotic drugs increase seizure frequency in epilepsy patients?","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2014.09.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. and ECNP. All rights reserved.","name":"copyright","label":"Copyright"}]}}